Pharmacokinetics of the 1.5 mg levonorgestrel emergency contraceptive in women with normal, obese and extremely obese body mass index

OBJECTIVE: To assess the pharmacokinetics (PK) of levonorgestrel after 1.5 mg oral doses (LNGEC) in women with normal, obese and extremely obese body mass index (BMI). STUDY DESIGN: The 1.5 mg LNG dose was given to healthy, reproductive-age, ovulatory women with normal BMI (mean 22.0), obese (mean 3...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Contraception
Asıl Yazarlar: Natavio, Melissa, Stanczyk, Frank Z, Molins, Emilie A G, Nelson, Anita, Jusko, William J
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6499670/
https://ncbi.nlm.nih.gov/pubmed/30703352
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.contraception.2019.01.003
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller